Press Releases September 9, 2026 09:17 AM

Virtuix to Highlight Accelerating Growth and Expanding Defense, Robotics and Healthcare Applications at H.C. Wainwright Conference

Virtuix Highlights Strong Quarterly Revenue Growth and Expansion into Defense, Robotics, and Healthcare at H.C. Wainwright Conference

By Caleb Monroe
Share
Twitter Reddit Facebook LinkedIn
VTIX

Virtuix Holdings Inc. announced that CEO Jan Goetgeluk will present at the H.C. Wainwright 28th Annual Global Investment Conference following quarterly revenue exceeding analyst estimates by over 50%. The company is expanding its Omni One platform into new high-growth sectors including defense, robotics, and healthcare, with notable partnerships and applications such as humanoid robotics with Tesla and autism therapy solutions.

Virtuix to Highlight Accelerating Growth and Expanding Defense, Robotics and Healthcare Applications at H.C. Wainwright Conference
VTIX
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Quarterly revenue surpassed analyst estimates by more than 50%, demonstrating strong financial momentum.
  • Expansion of Omni One full-body simulation system into defense (U.S. Marine Corps Counter-UAS training), robotics (collaboration with Tesla), and healthcare (autism therapy) markets.
  • Participation in a major investment conference provides opportunities to engage institutional investors and highlight broadening commercial applications of the technology.
  • Sectors impacted: Technology (AI and VR), Defense, Healthcare, Robotics, Consumer Electronics.

Company Recently Reported Quarterly Revenue More Than 50% Above Analyst Estimates as Omni One Expands into New High-Growth Markets

AUSTIN, Texas, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Virtuix Holdings Inc. (NASDAQ: VTIX), a leading developer of AI-driven, full-body simulation systems, today announced that Virtuix’s Founder, Chief Executive Officer, and Chairman, Jan Goetgeluk, will highlight the Company’s recent financial and commercial momentum at the H.C. Wainwright 28th Annual Global Investment Conference, being held September 14–16 at the Lotte New York Palace Hotel. Management’s meetings with institutional investors will follow a period of accelerating consumer demand and expanding commercial applications for Virtuix’s Omni One platform across defense, robotics, healthcare and enterprise markets.

Mr. Goetgeluk’s discussions will highlight recent developments including the Company’s expansion of Omni One within the Meta Quest ecosystem, humanoid robotics applications with Tesla, Counter-UAS training for the U.S. Marine Corps, and the growing use of Virtuix’s technology in healthcare applications, including autism therapy for children.

The H.C. Wainwright 28th Annual Global Investment Conference provides an opportunity for Virtuix to engage directly with institutional investors, family offices, and other members of the investment community.

“We entered this quarter with growing business momentum, following quarterly revenue that exceeded analyst expectations by more than 50%,” said Jan Goetgeluk. “Consumer demand for Omni One continues to grow, while the same underlying technology is gaining traction across defense, robotics, healthcare and enterprise applications. We look forward to presenting that broader Virtuix story directly to institutional investors at the H.C. Wainwright conference.”

H.C. Wainwright 28th Annual Global Investment Conference
Dates: September 14 – 16, 2026
Location: Lotte New York Palace Hotel, New York, NY
Conference Website: Here
Investor Registration: Here
Format: 1x1 Meetings
Attendees: Jan Goetgeluk, Founder, Chief Executive Officer, and Chairman

For more information on the H.C. Wainwright 28th Annual Global Investment Conference, or to schedule a meeting with management, please contact your H.C. Wainwright representative. You may also email your request to VTIX@mzgroup.us or call Chris Tyson at (949) 491-8235.

About Virtuix

Virtuix Holdings Inc. (NASDAQ: VTIX) is a leading manufacturer of AI-driven, full-body simulation systems for consumer, enterprise, and defense markets. The company’s premier portfolio of “Omni” omni-directional treadmills enables players to walk and run in 360 degrees without boundaries inside AI-generated worlds. With a focus on immersive entertainment, defense training, and enterprise applications, Virtuix continues to push the boundaries of full-body XR and AI-driven immersive experiences for users worldwide. For more information, visit virtuix.com.

Please visit the Company’s new Investor Relations website at invest.virtuix.com.

Disclaimer

Equity research services like Emerging Growth Research and Singular Research may receive compensation for services such as presenting at conferences, writing reports, or providing investor or public relations services. As a result, investors should be aware that equity research reports from these providers may have a conflict of interest that could affect the objectivity of these reports and their analyst estimates. Investors should consider these reports as only a single factor in making their investment decision.

Visit Us on Social Media:
LinkedIn
Instagram
Facebook
YouTube
TikTok
X

Company Contact
Lauren Premo
Virtuix Inc.
press@virtuix.com

Investor Relations Contact
Chris Tyson
MZ Group
Direct: 949-491-8235
VTIX@mzgroup.us


Risks

  • Continued growth depends on sustaining and expanding consumer and institutional demand across multiple sectors, which can be uncertain.
  • Dependence on partnerships with key players like Tesla and government contracts introduces execution risk.
  • Market competition and technological advancements may challenge Virtuix’s leadership in AI-driven full-body simulation systems.

More from Press Releases

USA Rare Earth Breaks Ground on Advanced Rare Earth Metal and Magnet Manufacturing Facility in Blacksburg, South Carolina Sep 9, 2026 NeOnc Raises $15 Million At Market Adding Fuel to the Strong NEO100 Data Sep 9, 2026 Rogers Xfinity Adds Exclusive Sportsnet+ Content to TV Packages at No Additional Cost Sep 9, 2026 Oxbridge to Attend H.C. Wainwright’s 28th Annual Global Investment Conference in New York Sep 9, 2026 Nutriband CEO, Gareth Sheridan to Attend the Nasdaq Life Sciences Advisory Board (LaB) Biotech Summit Sep 9, 2026